baclofen has been researched along with Hyperglycemia in 3 studies
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effects of intrahypothalamic or hippocampal injection of GABA receptor agonists on hyperglycemia induced by hippocampal neostigmine." | 7.68 | Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats. ( Hiyoshi, Y; Iguchi, A; Maeda, N; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
| "We investigated the effect of GABA receptor agonists on the central nervous system (CNS)-mediated hyperglycemia induced by neostigmine or histamine in anesthetized fed rats." | 7.68 | Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia. ( Hiyoshi, Y; Iguchi, A; Li, X; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
| "We investigated the effects of intrahypothalamic or hippocampal injection of GABA receptor agonists on hyperglycemia induced by hippocampal neostigmine." | 3.68 | Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats. ( Hiyoshi, Y; Iguchi, A; Maeda, N; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
| "We investigated the effect of GABA receptor agonists on the central nervous system (CNS)-mediated hyperglycemia induced by neostigmine or histamine in anesthetized fed rats." | 3.68 | Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia. ( Hiyoshi, Y; Iguchi, A; Li, X; Miura, H; Nonogaki, K; Ozawa, K; Sakamoto, N; Tamagawa, T; Watanabe, G, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saengboonmee, C | 1 |
| Sorin, S | 1 |
| Sangkhamanon, S | 1 |
| Chomphoo, S | 1 |
| Indramanee, S | 1 |
| Seubwai, W | 1 |
| Thithuan, K | 1 |
| Chiu, CF | 1 |
| Okada, S | 1 |
| Gingras, MC | 1 |
| Wongkham, S | 1 |
| Ozawa, K | 2 |
| Miura, H | 2 |
| Tamagawa, T | 2 |
| Hiyoshi, Y | 2 |
| Nonogaki, K | 2 |
| Maeda, N | 1 |
| Watanabe, G | 2 |
| Sakamoto, N | 2 |
| Iguchi, A | 2 |
| Li, X | 1 |
3 other studies available for baclofen and Hyperglycemia
| Article | Year |
|---|---|
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus.
Topics: Baclofen; beta Catenin; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Prolif | 2023 |
Intrahypothalamic, but not hippocampal, administration of muscimol suppresses hyperglycemia induced by hippocampal neostigmine in anesthetized rats.
Topics: Analysis of Variance; Animals; Baclofen; Blood Glucose; Epinephrine; Hepatic Veins; Hippocampus; Hyp | 1993 |
Activation of GABAA receptor in the brain suppresses neostigmine or histamine-induced central nervous system-mediated hyperglycemia.
Topics: Animals; Baclofen; Brain; Central Nervous System; Histamine; Histamine Antagonists; Hyperglycemia; I | 1993 |